InvestorsHub Logo

ronpopeil

10/11/19 10:32 AM

#401 RE: banman87 #400

agreed. i have owned this one for a while. most of my shares were bought around $1.60. i would listen to the conference calls and thought they had an amazing story developing but the stock never reacted. finally people realized what was going on and here we are over $6. if they can execute like mark says, and that humanized glyco program is successful, which i believe it will be, we could be talking about a $60-$100 stock given the share structure. i doubt they will remain independent long term

TheMonolith

10/11/19 1:47 PM

#402 RE: banman87 #400

Thanks for the report! It scares me a little when a CEO says investors should own. There's still always the chance that there's more hype than substance here, but I hold a strong position. I believe the sale to Dupont, the fiduciary duty they carry with skin in the game and heavy cash levels, along with great collaborations are reasons to believe. One of the best risk to reward plays you can find. Just need that big milestone payment, and it's off to the races. Exciting stock that could hit suddenly or take a few years. I'm holding through thick and thin and hope to wake up to $30+ one day.

Paullee

10/18/19 11:20 AM

#431 RE: banman87 #400

My biggest concern. They have a lot of stuff in the cookie jar. When does someone really put their hand in and pay big bucks? Because once they do take a cookie, it can be years for them to develop it and the royalties to roll in. Or it may take years for us to develop something on our own.

Also, in the last two talks mark has talked about the big sales he has made in the past, over 4 years ago,
DuPont, shell, bdg, codesix(sp?) and how they have put 100’s of,millions into more R&D.
When do we ever see royalties from thos deals

Any thoughts?